Clinical Trial: Biomarker Testing to Predict Radiation-Related Heart Disease in Lung Cancer Patients

U.S., Oct. 10 -- ClinicalTrials.gov registry received information related to the study (NCT07869329) titled 'Biomarker Testing to Predict Radiation-Related Heart Disease in Lung Cancer Patients' on Oct. 06.

Brief Summary: The study will measure serum Pro-N-Cadherin and NT-proBNP (pro B-type natriuretic peptide) levels in adults with non-small cell lung cancer receiving hypofractionated radiation therapy and evaluate whether these biomarkers correlate with radiation dose to the heart, cardiac dysfunction, and adverse cardiac events. Participants will undergo blood collection and echocardiography over a two-year follow-up period.

Study Start Date: Nov., 2026

Study Type: INTERVENTIONAL

Condition: Non-Small Cell Lung Cancer Radiation-Induc...